- Home
- ANY vs HOOK Comparison
ANY vs HOOK Comparison
Compare ANY & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANY
- HOOK
- Stock Information
- Founded
- ANY N/A
- HOOK 2011
- Country
- ANY United States
- HOOK United States
- Employees
- ANY N/A
- HOOK N/A
- Industry
- ANY Finance: Consumer Services
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- ANY Finance
- HOOK Health Care
- Exchange
- ANY Nasdaq
- HOOK Nasdaq
- Market Cap
- ANY 15.7M
- HOOK 15.3M
- IPO Year
- ANY N/A
- HOOK 2019
- Fundamental
- Price
- ANY $0.76
- HOOK $1.20
- Analyst Decision
- ANY Strong Buy
- HOOK Buy
- Analyst Count
- ANY 1
- HOOK 4
- Target Price
- ANY $3.00
- HOOK $10.67
- AVG Volume (30 Days)
- ANY 1.0M
- HOOK 58.3K
- Earning Date
- ANY 08-12-2025
- HOOK 08-07-2025
- Dividend Yield
- ANY N/A
- HOOK N/A
- EPS Growth
- ANY N/A
- HOOK N/A
- EPS
- ANY N/A
- HOOK N/A
- Revenue
- ANY $12,479,000.00
- HOOK $9,351,000.00
- Revenue This Year
- ANY N/A
- HOOK N/A
- Revenue Next Year
- ANY N/A
- HOOK N/A
- P/E Ratio
- ANY N/A
- HOOK N/A
- Revenue Growth
- ANY N/A
- HOOK N/A
- 52 Week Low
- ANY $0.36
- HOOK $0.72
- 52 Week High
- ANY $1.90
- HOOK $6.69
- Technical
- Relative Strength Index (RSI)
- ANY 64.26
- HOOK 38.53
- Support Level
- ANY $0.56
- HOOK $1.13
- Resistance Level
- ANY $0.67
- HOOK $1.25
- Average True Range (ATR)
- ANY 0.07
- HOOK 0.06
- MACD
- ANY 0.02
- HOOK -0.00
- Stochastic Oscillator
- ANY 73.30
- HOOK 31.51
About ANY Sphere 3D Corp.
Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.